As above but knockdown efficiency of KAP-1 siRNA was assessed under single, double and triple knockdown conditions. C-D) BRCA1 single and pool oligonucleotide knockdown efficiency was assessed by immunoblotting and immunostaining. For immunoblotting, MCM6 was used as a loading control. E) 53BP1 knockdown efficiency was monitored by IF following, single, double, triple and quadruple knockdown conditions. 53BP1 levels were greatly diminished in all cases although in the triple and quadruple knockdown conditions slightly more 53BP1 remained. F-I) 53BP1, KAP-1, DNAPK and KAP-1 knockdown efficiencies were assessed by western blotting, following single and multiple knockdown conditions. Ku80, α-tubulin and KAP-1 were used as loading controls.
Supplementary Figure 2.
(A) Highly resolved images of multiple focal planes through the nucleus (z-stacks) were taken using a confocal Zeiss LSM 510 microscope. Z-stacks were further processed using 3D image. The resulting 2D images were analyzed using Image J. The Analysis involves setting the threshold in each image for the heterochromatin and the RPA-foci and capturing the total number of RPA2 foci and the overlap of RPA2 foci and heterochromatin (setting a minimal size for the foci as a requirement).
Supplementary Figure 3. Controls for IP experiments.
A) HeLa cells were synchronized using a double thymidine block. 2 mM thymidine was added to adherent HeLa cells. 15h later, the cells were washed and incubated in thymidine free media for 8h. 2 mM thymidine was then re-added, and the cells were grown for a further 15h. At this point, the cells were highly synchronized in G1 phase (left panel) (no pH3 + cells).
Upon removal of thymidine and the addition of fresh media, the cells progressed through the C) SCEs in Wild type (WT) and 53BP1 -/-MEFs following HU. In these experiments using MEFs, we observed enhanced SCEs in the untreated control compared to the untreated control in Figure 2C . We attribute this difference to the addition of aphidicolin to cells in Figure 2C but not here (Fig. S4C ). With MEFs, we have observed that aphidicolin does not Figure S1
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